| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/06/2011 | EP2305823A1 Materials and methods relating to protein aggregation in neurodegenerative disease |
| 04/06/2011 | EP2305822A2 Methods and compositions for diseases associated with Amyloidosis |
| 04/06/2011 | EP2305821A2 Protease variants |
| 04/06/2011 | EP2305820A1 Xylanases, nucleic acids encoding them and methods for making and using them |
| 04/06/2011 | EP2305818A2 Antigen constructs useful in the detection and differentiation of antibodies to HIV |
| 04/06/2011 | EP2305817A2 Anti-IL-12 antibodies, compositions, methods and uses |
| 04/06/2011 | EP2305816A1 Mutation in the Parkin gene, compositions, methods and uses |
| 04/06/2011 | EP2305815A1 Method for producing a peptide with a pI above 8 or below 5 |
| 04/06/2011 | EP2305814A2 Gene of porcine alpha-s1 casein, a promoter of the same and use thereof |
| 04/06/2011 | EP2305813A2 Fuctional and hyperfunctional sirna |
| 04/06/2011 | EP2305812A2 Fuctional and hyperfunctional sirna |
| 04/06/2011 | EP2305811A1 Method of diagnosing smal cell lung cancer |
| 04/06/2011 | EP2305810A1 miRNAs in the treatment of fibrosis |
| 04/06/2011 | EP2305809A2 Methods for nucleic acid isolation and kits using a microfluidic device and concentration step |
| 04/06/2011 | EP2305808A1 Templated molecules and methods for using such molecules |
| 04/06/2011 | EP2305807A1 Method for detecting or quantifying dna |
| 04/06/2011 | EP2305806A1 Method for detecting or quantifying dna |
| 04/06/2011 | EP2305805A1 Double-stranded polynucleotide |
| 04/06/2011 | EP2305804A1 MonoPEGylated human growth hormone |
| 04/06/2011 | EP2305803A1 Thermostable 1,5-anhydroglucitol dehydrogenase, and method for measurement of 1,5-anhydroglucitol by using the same |
| 04/06/2011 | EP2305802A1 Modified vitamin K-dependent polypeptides |
| 04/06/2011 | EP2305801A1 Novel variant hyprocrea jecorina CBH1 cellulases |
| 04/06/2011 | EP2305800A1 Novel variant hyprocrea jecorina cbh1 cellulases |
| 04/06/2011 | EP2305799A2 Maltogenic alpha-amylase variants |
| 04/06/2011 | EP2305798A2 Detection of mutations in a gene associated with resistance to viral infection, OAS1 |
| 04/06/2011 | EP2305797A2 Low-lipoxygenase 1 barley |
| 04/06/2011 | EP2305795A1 Method of collecting placental stem cells |
| 04/06/2011 | EP2305794A1 Expansion of renewable stem cell populations |
| 04/06/2011 | EP2305717A1 Inhibiting TNIK for treating colon cancer |
| 04/06/2011 | EP2305715A2 Monoclonal antibody to osteoprotegerin binding protein |
| 04/06/2011 | EP2305714A2 Anti-interferon-alpha subtypes antibodies |
| 04/06/2011 | EP2305713A1 Human antibodies that bind human TNFalpha |
| 04/06/2011 | EP2305712A1 Human antibodies that bind human TNFalpha |
| 04/06/2011 | EP2305710A2 Synthetic antibody phage libraries |
| 04/06/2011 | EP2305709A1 Recombinant antibodies specific for beta-amyloid ends, DNA encoding and methods for use thereof |
| 04/06/2011 | EP2305703A1 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
| 04/06/2011 | EP2305702A1 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
| 04/06/2011 | EP2305699A1 Stabilised mRNA with increased G/C content which is optimised for translation in its coded areas |
| 04/06/2011 | EP2305302A2 Prevention and treatment of amyloidogenic disease |
| 04/06/2011 | EP2305300A1 Pharmaceutical composition for treatment and prevention of cancer |
| 04/06/2011 | EP2305299A1 Chimeric alphavirus replicon particles |
| 04/06/2011 | EP2305282A2 Prevention and treatment of amyloidogenic disease |
| 04/06/2011 | EP2305247A2 Methods for detecting and reversing resistance to macrocyclic lactone compounds |
| 04/06/2011 | EP2305027A2 Transgenic mammals having human Ig loci including plural VH and Vkappa regions and antibodies produced therefrom |
| 04/06/2011 | EP2305025A1 Genetically modified plant capable of biosynthesizing capsinoid |
| 04/06/2011 | EP2304046A1 Factor viii muteins with reduced immunogenicity |
| 04/06/2011 | EP2304045A1 Chaperone toolbox |
| 04/06/2011 | EP2304041A1 Method of producing yeast biomass |
| 04/06/2011 | EP2304040A2 Production of alkenes by enzymatic decarboxylation of 3-hydroxyalkanoic acids |
| 04/06/2011 | EP2304038A2 Brassica plant comprising a mutant indehiscent allelle |
| 04/06/2011 | EP2304037A1 Plants having enhanced yield-related traits and a method for making the same |
| 04/06/2011 | EP2304036A2 Methods and means of increasing the water use efficiency of plants |
| 04/06/2011 | EP2304035A2 Fusion protein and use thereof |
| 04/06/2011 | EP2304034A1 An adapter molecule for the delivery of adenovirus vectors |
| 04/06/2011 | EP2304033A2 Functionalized polypeptides |
| 04/06/2011 | EP2304032A1 6 desaturases and their use in making polyunsaturated fatty acids |
| 04/06/2011 | EP2304031A2 Inhibition of hrp-3 using modified oligonucleotides |
| 04/06/2011 | EP2304030A1 Recombinant dna constructs and methods for modulating expression of a target gene |
| 04/06/2011 | EP2304029A1 Surface display of whole antibodies in eukaryotes |
| 04/06/2011 | EP2304028A1 Methods and kits for extraction of dna |
| 04/06/2011 | EP2304027A1 Protein expression |
| 04/06/2011 | EP2304026A2 Nanoparticle compositions for nucleic acids delivery system |
| 04/06/2011 | EP2304025A1 Minicircle dna vector preparations and methods of making and using the same |
| 04/06/2011 | EP2304024A2 Avian reoviridae |
| 04/06/2011 | EP2303921A2 Mutated netrin-4 proteins, fragments thereof and their uses as drugs |
| 04/06/2011 | EP2303912A1 Cdca1 epitope peptides and vaccines containing the same |
| 04/06/2011 | EP2303909A1 Iqgap3 epitope peptides and vaccines containing the same |
| 04/06/2011 | EP2303458A1 Nucleic acid extraction apparatus |
| 04/06/2011 | EP2303405A1 Apparatus and methods for controlling cellular development |
| 04/06/2011 | EP2303334A1 Vector |
| 04/06/2011 | EP2303323A1 Modified beta-lactoglobulins for immunotherapy of milk allergy |
| 04/06/2011 | EP2303322A1 Recombinant modified vaccinia virus measles vaccine |
| 04/06/2011 | EP2303316A1 Constructing a dna chimera for vaccine development against leishmaniasis and tuberculosis |
| 04/06/2011 | EP2123754B1 CHIMERIC Fc GAMMA RECEPTOR AND METHOD FOR DETERMINATION OF ADCC ACTIVITY BY USING THE RECEPTOR |
| 04/06/2011 | EP1943345B1 A method for the transfer of episomal vectors into animal cells |
| 04/06/2011 | EP1846378B1 Cationic lipids for the transfection of nucleic acids |
| 04/06/2011 | EP1838737B1 Binding proteins specific for human matriptase |
| 04/06/2011 | EP1651750B1 Lactobacillus acidophilus nucleic acids encoding fructo-oligosaccharide utilization compounds and uses thereof |
| 04/06/2011 | EP1599586B1 Rna-interference for znfn3a1-gene as a method for inhibiting cancer cell growth |
| 04/06/2011 | EP1594889B1 Nell peptide expression systems and bone formation activity of nell peptide |
| 04/06/2011 | EP1529113B1 Vaccinia virus host range genes to increase the titer of avipoxviruses |
| 04/06/2011 | EP1485056B1 Methods of using fet labeled oligonucleotides that include a'5' exonuclease resistant quencher domain and compositions for practicing the same |
| 04/06/2011 | EP1430071B1 Secreted and cell surface genes expressed in benign and malignant colorectal tumors |
| 04/06/2011 | EP1417237B1 Process for preparation of polypeptides of interest from fusion peolypeptides |
| 04/06/2011 | EP1411979B1 Vaccine comprising gp120 and nef and/or tat for the immunisation against hiv |
| 04/06/2011 | EP1407030B1 Methods for large scale production of recombinant dna-derived tpa or k2s molecules |
| 04/06/2011 | EP1291424B1 Gasc1 gene |
| 04/06/2011 | CN1997744B Generation of plants with altered oil content |
| 04/06/2011 | CN1953987B Method for construction and use of kluyveromyces lactis promoter variants in k. lactis that substantially lack e. coli transcriptional capability |
| 04/06/2011 | CN1910284B Epitope/peptide recognized by HLA-A2402-restricted Ep-CAM-specific CTL and use of the same |
| 04/06/2011 | CN1886510B Artificial bidirectional promoter for activation of gene expression |
| 04/06/2011 | CN1875095B Recombinant microorganism |
| 04/06/2011 | CN1871349B Method and kit for estimating side effect by paclitaxel therapy |
| 04/06/2011 | CN1836046B Moss expressing promoting regions |
| 04/06/2011 | CN1836038B Methods for producing secreted polypeptides |
| 04/06/2011 | CN1832961B Fungus resistant plants and their uses |
| 04/06/2011 | CN1774447B S. pneumoniae antigens |
| 04/06/2011 | CN102007221A Methods for detection of a target nucleic acid by forming a cleavage structure with a cleavage resistant probe |
| 04/06/2011 | CN102007215A Compositions and methods for the suppression of target polynucleotides from lygus |
| 04/06/2011 | CN102007214A Nucleotide sequences and corresponding polypeptides conferring improved nitrogen use efficiency characteristics in plants |